SelvitaWAR:SLV +3.27%81 FCF Margin % is 6.90% as of Mar. 2026, which is 34% below its 10-year median of 10.45. GuruFocus rates WAR:SLV with a GF Score™ of 81/100 and a GF Value™ of zł58.46 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Selvita ranks better than 86.27% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Selvita's Free Cash Flow for the
three
months ended in Mar. 2026 was zł5.2 Mil. Selvita's Revenue for the
three
months ended in Mar. 2026 was zł75.8 Mil. Therefore, Selvita's FCF Margin % for the quarter that ended in Mar. 2026 was 6.90%.
The historical rank and industry rank for Selvita's FCF Margin % or its related term are showing as below:
WAR:SLV'
s FCF Margin % Range Over the Past 10 Years
Min: -57.11 Med: 10.45 Max: 19.28
Current: 18.03
During the past 11 years, the highest FCF Margin % of Selvita was 19.28%. The lowest was -57.11%. And the median was 10.45%.
WAR:SLV's FCF Margin % is ranked better than 86.27% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs WAR:SLV: 18.03
Selvita FCF Margin % Related Terms
Selvita FCF Margin % Historical Data
* Premium members only.
The historical data trend for Selvita's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:SLV vs TMO, DHR, IDXX: FCF Margin % Comparison
For the Diagnostics & Research subindustry, Selvita's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selvita FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Selvita's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selvita (WAR:SLV) has a FCF Margin % of 6.90% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Selvita and its competitors. This is 34% below median its historical median of 10.45. According to the industry distribution chart, Selvita ranks #28 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 13.7%.
Is Selvita's FCF Margin % too high?
Selvita's current FCF Margin % of 6.90% is 34% below median its 10-year median of 10.45. Based on the distribution chart, Selvita ranks #28 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Selvita has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Selvita's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Selvita ranks #28 out of 204 companies for FCF Margin %. This places Selvita in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Selvita and its competitors. Selvita's current FCF Margin % is 6.90%, which is 34% below median its own 10-year median of 10.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selvita stock overvalued right now?
Based on GuruFocus' analysis, Selvita (WAR:SLV) is currently considered Significantly Undervalued. The stock's GF Value™ is zł58.46, compared to a current price of zł31.60 — trading 45.9% below its estimated fair value. The current FCF Margin % is 6.90%, which is 34% below median its 10-year median of 10.45. Selvita's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Selvita (WAR:SLV), the current FCF Margin % is 6.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selvita (WAR:SLV) Overvalued in 2026?
Based on GuruFocus' analysis, Selvita stock appears to be undervalued.
The current stock price of zł31.60 is trading 45.9% below its estimated GF Value™ of zł58.46.
GuruFocus considers Selvita to be Significantly Undervalued.
Key valuation signals for WAR:SLV:
FCF Margin %: 6.90% (34% below median its 10-year median of 10.45)
GF Value™: zł58.46 vs. price of zł31.60 (45.9% below fair value)
No single metric tells the full story. See the WAR:SLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
81GF Score
Get the complete analysis for WAR:SLV
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SLV has been successfully added to your 
